Ovary removal at younger age can lead to cognitive decline
HQ Team June 27, 2024: A new study has found that the removal of both ovaries can have long-term health consequences The US.
Drugs
Health
Medical
Drugs
Health
Pharma
Multivitamins play no role in improving your life span, finds study
HQ Team June 27, 2024:The ongoing debate about the perceived benefits or non-benefits of vitamin supplements has another study that emphasises their nil.
Drugs
Health
Pharma
USFDA issues new draft guidance for trials to expand race, ethnicity
In a bid to include an under-represented population, the US drug regulator has advised healthcare firms to improve racial, ethnic and other diversity.
Drugs
Health
Pharma
Novo’s end-stage hypertension trial drug fails, $817m impairment loss
Novo Nordisk’s end-stage trial for hypertension drug has failed to meet its primary goal and the Danish multinational has recognised an impairment loss.
Drugs
Health
Pharma
Opinion: Ecstasy drug-driven PSTD treatment faces tough questions
MDMA-assisted psychotherapy is a breakthrough in the treatment of PTSD, but without proper monitoring and documentation, we are inviting trouble.
Drugs
Health
Pharma
Alcohol claims 2.6 million lives yearly, 209m people are dependent: WHO
About 400 million people globally live with alcohol and drug use disorders and of the total, 209 million people have alcohol dependence, according.
Drugs
Health
Pharma
Global fight against trans fats proving successful as more nations join: UN
Fifty-three nations have adopted best practice policies to eliminate trans fats in foods — benefitting 46% of the world’s population, or about 3.7.
Drugs
Health
Pharma
Teva to sell generic version of Novo Nordisk’s diabetic drug in US
Israel’s Teva Pharmaceuticals will start selling a generic version of Novo Nordisk’s type 2 diabetic drug Victoza in the US market.
Drugs
Health
Pharma
Novo Nordisk to set up $4.1 billion injectables facility in US’s North Carolina
Novo Nordisk, a Danish pharmaceutical multinational, will invest $4.1 billion to build a new factory in the US to make obesity and chronic.
Drugs
Health
Pharma
FDA gives nod to Bristol Myer’s colorectal cancer therapy
The US Food and Drug Administration has greenlighted Bristol Myers Squibb’s combination therapy to treat metastatic colorectal cancer in patients with a mutated.